These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10690822

  • 1. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis.
    Akpek EK, Hasiripi H, Christen WG, Kalayci D.
    Ophthalmology; 2000 Feb; 107(2):263-9. PubMed ID: 10690822
    [Abstract] [Full Text] [Related]

  • 2. Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study.
    Jain AK, Sukhija J.
    Indian J Ophthalmol; 2006 Jun; 54(2):111-6. PubMed ID: 16770028
    [Abstract] [Full Text] [Related]

  • 3. Topical cyclosporine in vernal keratoconjunctivitis.
    Bleik JH, Tabbara KF.
    Ophthalmology; 1991 Nov; 98(11):1679-84. PubMed ID: 1800929
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK, Dart JK, Watson S, Christen W, Dursun D, Yoo S, O'Brien TP, Schein OD, Gottsch JD.
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of topical azelastine compared with topical mitomycin C in patients with allergic conjunctivitis.
    Sodhi PK, Pandey RM, Ratan SK.
    Cornea; 2003 Apr; 22(3):210-3. PubMed ID: 12658084
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A, Gürler B.
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
    Sharma A, Gupta R, Ram J, Gupta A.
    Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
    [Abstract] [Full Text] [Related]

  • 11. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
    Kosrirukvongs P, Luengchaichawange C.
    J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
    [Abstract] [Full Text] [Related]

  • 12. [Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis].
    Hida WT, Nogueira DC, Schaefer A, Dantas PE, Dantas MC.
    Arq Bras Oftalmol; 2006 Feb; 69(6):851-6. PubMed ID: 17273679
    [Abstract] [Full Text] [Related]

  • 13. A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone-like papillae in severe atopic and vernal keratoconjunctivitis.
    Tanaka M, Takano Y, Dogru M, Fukagawa K, Asano-Kato N, Tsubota K, Fujishima H.
    Cornea; 2004 May; 23(4):326-9. PubMed ID: 15097124
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H, McCormick SA, Finger PT.
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mitomycin-C and vernal conjunctivitis.
    Pandey SK, Saini JS, Werner L, Apple DJ.
    Ophthalmology; 2000 Dec; 107(12):2125-7. PubMed ID: 11097575
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.